Webinar Update June 8th 1pm EDT Hosted by CEO David Regan & CSO Len Pagliaro PhD

Join Sona Nanotech for a live investor webinar hosted by David Regan, CEO and Len Pagliaro PhD, CSO on which they will discuss the development of Sona’s pre-clinical Targeted Hyperthermia Therapy, which leverages Sona’s biocompatible Gold Nanorods.

The webinar will include a Q&A session.

Join Webinar

Subscribe to Our Newsletter

Download the Company Presentation

Read or Download the Latest White Paper

The Case for Hyperthermia Thermal Therapy for Cancer - White Paper - Sona Nanotech

The Case for “Hyperthermia” Thermal Therapy for Cancer